research SARS‐CoV‐2‐induced telogen effluvium: a multicentric study
COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.
Search
for
Sort by
Research
330-360 / 1000+ results 
research Relative changes in the pattern of diseases presenting in dermatology outpatient clinic in the era of the COVID ‐19 pandemic
During the COVID-19 pandemic, a clinic in Turkey saw fewer patients but more cases of certain skin conditions, possibly linked to the virus and stress.
research Analysis of dermatologic conditions in Turkey and Italy by using Google Trends analysis in the era of the COVID ‐19 pandemic
Searches for acne, hair loss, and eczema increased during COVID-19, while searches for other skin issues decreased.
research Dermatological complications due to post‑COVID‑19 syndrome: A systematic review
Nearly 20% of recovered COVID-19 patients have skin issues, with hair loss and rashes being common.
research Reply to: “Comment on ‘Androgenetic alopecia present in the majority of patients hospitalized with COVID-19’”
High incidence of hair loss found in COVID-19 patients, but no severity correlation established.
research Case Report: Alopecia areata in an adolescent after COVID-19 infection
COVID-19 may trigger hair loss conditions like alopecia areata.
research Investigating Biochemical Biomarkers in Telogen Effluvium Post-COVID-19 Patients: A Retrospective Cohort Study
COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.
research INFLUÊNCIA DO VÍRUS DA COVID-19 NO AUMENTO DO NÚMERO DE CASOS DE EFLÚVIO TELÓGENO
COVID-19 may increase hair loss due to stress and inflammation.
research Scalp capillarectasia as a trichoscopic sign of COVID ‐19‐associated telogen effluvium
Dilated scalp capillaries might be a sign of hair loss related to COVID-19.
research Efluvio telógeno y Covid-19
COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.
research A case of rapid progression of central centrifugal cicatricial alopecia after COVID-19 infection
COVID-19 may worsen hair loss in people with a certain type of scarring alopecia, but early treatment can help improve symptoms and hair regrowth.
research Reporting Cases of Telogen Effluvium as a sequelae of COVID‐19 Infection
COVID-19 can cause temporary hair loss, known as Telogen Effluvium, within two months of infection.
research Clinical Signs and Laboratory Tests for the Differential Diagnosis ofAndrogenic and Post-COVID-19 Alopecia in Women
Post-COVID-19 hair loss is different from androgenetic alopecia and can be identified by lower copper and higher selenium levels.
research Androgenetic alopecia in women and men is not related to COVID‐19 infection severity: a prospective cohort study of hospitalized COVID‐19 patients
Hair loss doesn't affect COVID-19 severity.
research Black dots in trichoscopy after COVID‐19. Can it be telogen effluvium?
A woman's hair loss after COVID-19 was likely due to a mix of pressure-induced alopecia and acute telogen effluvium.
research Rehabilitation therapy for a severe case of coronavirus disease 2019: a case report
Rehabilitation therapy helped a severe COVID-19 patient regain muscle mass and return to normal life.
research 32731 Alopecia in COVID-19 patients: Systematic review and meta-analysis
Different types of hair loss are linked to COVID-19, with some types possibly increasing risk of getting the virus, while others may be triggered or worsened by the virus.
research Risks of alopecia areata in long COVID: Binational population‐based cohort studies from South Korea and Japan
COVID-19 increases the risk of hair loss, but vaccination can reduce this risk.
research Intermittent chronic telogen effluvium with an unusual dermoscopic finding following COVID ‐19
A 17-year-old girl had severe, on-and-off hair loss, likely due to COVID-19. She was treated with Vitamin D3, biotin, and other supplements, and saw some improvement within a month.
research COVID-19 with High Fever: A Trigger Factor for Alopecia Areata?
High fever from COVID-19 might trigger hair loss.
research Alopecia Universalis after COVID-19 Vaccination: Case Report and Literature Review
A COVID-19 vaccine may trigger severe hair loss in rare cases.
research 5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia (vol 35, pg e243, 2021)
Men with hair loss who take a certain type of medication may experience fewer COVID-19 symptoms.
research Clinical course of alopecia after COVID-19
A man experienced hair loss after getting COVID-19, which improved with treatment and might have been triggered by stress related to the illness.
research The Dermatological Spectrum of Coronavirus Disease-19 Disease: Cutaneous Signs for Diagnostics and Prognosis and an Expanded Classification
Skin problems like rashes and hair loss can help diagnose and predict COVID-19.
research Red nail bands in conjunction with telogen effluvium as a post‐COVID‐19 phenomenon
Red stripes on nails and hair loss may occur after COVID-19.
research EVALUATION OF ASSOCIATION OF ANTHROPOMETRIC INDICES WITH STRESS RESPONSE IN PCOS POPULATION
Stress worsens symptoms and body changes in women with PCOS, especially during COVID-19.
research Comparison of Telogen Effluvium Incidence in Hospitalized and Outpatient Settings after Recovery from COVID-19.
More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.
research Effect of age and gender on alopecia in patients hospitalized with COVID-19
Older male COVID-19 patients are more likely to experience hair loss.
research Lilly arthritis drug approved for alopecia
The drug Olumiant is now approved to treat severe hair loss from alopecia and can also be used for some hospitalized COVID-19 patients.
research A Case of Telogen Effluvium as COVID Sequelae
A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.